Nicolas Williet

9PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 14, 2026
Predictors of Biliary Drainage Dysfunction Following EUS-Guided Gallbladder Drainage for Malignant Distal Biliary Obstruction: A Multicenter Retrospective Study: GALLBLADEUS-2.

|Apr 14, 2026
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP.

Christelle de la Fouchardière, Aziz Zaanan, Aymeric de Montfort

|Oct 06, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi).

Marine Valery, Julien Edeline, Julie Henriques

|Jan 17, 2024
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.

Christelle De La Fouchardière, David Malka, Claire Cropet

|Dec 23, 2022
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study.

Marie Auvray Kuentz, Vincent Hautefeuille, Louis de Mestier

|Jul 21, 2021
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial.

Laetitia Dahan, Nicolas Williet, Karine Le Malicot

Pageof 2

Frequent Collaborators

3 joint publications

Christelle de La Fouchardière

3 joint publications

David Malka

2 joint publications

Vincent Hautefeuille

2 joint publications

David Tougeron